Litcius/Paper detail

Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease

Aude Kopp, O. Mangin, Laurène Gantzer, Béranger Lekens, Guy G. Simoneau, M. Ando Ravelomanantsoa, John Evans, Jean‐François Bergmann, Pierre Sellier

2020Human Vaccines & Immunotherapeutics26 citationsDOIOpen Access PDF

Abstract

CAP: community-acquired pneumonia; COPD: chronic obstructive pulmonary diseases; CHF: congestive heart failure; DM: diabetes mellitus; IPD: invasive pneumococcal disease; HIV: human immunodeficiency virus; PVC: pneumococcal vaccination coverage; PCV7: 7-valent pneumococcal conjugate vaccine; PCV13: 13-valent pneumococcal conjugate vaccine; PPSV23: 23-valent pneumococcal polysaccharide vaccine; GPs: general practitioners; CLM: Cegedim Logiciels Médicaux; MLM: monLogicielMedical; ICD-10: International Classification of Diseases; CNIL: Commission nationale de l'informatique et des libertés; HPV: human papillomavirus; HBV: hepatitis B virus.

Topics & Concepts

MedicineVaccinationStreptococcus pneumoniaePneumococcal pneumoniaPneumococcal infectionsCOPDPneumoniaPneumococcal polysaccharide vaccinePneumococcal vaccinePopulationMeningitisPediatricsInternal medicineImmunologyIntensive care medicinePneumococcal diseaseEnvironmental healthBiologyBacteriaGeneticsPneumonia and Respiratory InfectionsPneumocystis jirovecii pneumonia detection and treatmentRespiratory viral infections research
Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease | Litcius